Synapse - Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status"

Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status" Journal Article

Authors:	LaFave, L. M.; Béguelin, W.; Koche, R.; Teater, M.; Spitzer, B.; Chramiec, A.; Papalexi, E.; Keller, M. D.; Hricik, T.; Konstantinoff, K.; Micol, J. B.; Durham, B.; Knutson, S. K.; Campbell, J. E.; Blum, G.; Shi, X.; Doud, E. H.; Krivtsov, A. V.; Chung, Y. R.; Khodos, I.; De Stanchina, E.; Ouerfelli, O.; Adusumilli, P. S.; Thomas, P. M.; Kelleher, N. L.; Luo, M.; Keilhack, H.; Abdel-Wahab, O.; Melnick, A.; Armstrong, S. A.; Levine, R. L.
Article Title:	Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status"
Journal Title:	Nature Medicine
Volume:	22
Issue:	6
ISSN:	1078-8956
Publisher:	Nature Publishing Group
Date Published:	2016-06-01
Start Page:	578
End Page:	579
Language:	English
DOI:	10.1038/nm.4094
PROVIDER:	scopus
PUBMED:	27270773
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-84976415504&partnerID=40&md5=23e988c929ad43300c593d176e80ba52
Notes:	Letter -- Export Date: 2 August 2016 -- Source: Scopus